Day: March 9, 2026

Design Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Updates

Written by Customer Service on March 9, 2026. Posted in Earnings Releases And Operating Results.

Trials for DT-216P2 (RESTORE-FA) and DT-168 (FECD) Ongoing; DT-818 (DM1) Dosing in Patients Expected in the First Half of 2026 Cash and Securities of $219.8 Million as of Year-End Supports Ongoing Clinical Execution CARLSBAD, Calif., March 09, 2026 (GLOBE NEWSWIRE) — Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today reported fourth quarter and full year 2025 financial results and highlighted business updates and upcoming milestones across its GeneTAC® portfolio. “The fourth quarter capped a year of strong execution and meaningful progress across our GeneTAC® portfolio,” said Pratik Shah, Ph.D., chairperson and chief executive officer of Design Therapeutics. “We enter 2026 with three clinical programs advancing toward important...

Voyager Reports Fourth Quarter and Full Year 2025 Financial and Operating Results

Written by Customer Service on March 9, 2026. Posted in Earnings Releases And Operating Results.

– Transformative year for tau in AD: VY1706 clinical entry and VY7523 clinical data anticipated H2 2026 – – Validating brain-targeted capsids in humans: expect two I.V.-delivered neuro gene therapies to enter clinic H2 2026 – – Advancing Voyager NeuroShuttle™: murine study using anti-amyloid antibody supports sustained brain exposure profile – – Ended 2025 with cash position of $202 million, expected to maintain runway into 2028 – LEXINGTON, Mass., March 09, 2026 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging genetics to treat neurological diseases, today reported fourth quarter and full year 2025 financial and operating results. “Building on our pipeline progress in 2025, Voyager expects 2026 to be a pivotal year...

MacroGenics Reports 2025 Financial Results and Highlights Upcoming Planned Data Disclosures

Written by Customer Service on March 9, 2026. Posted in Earnings Releases And Operating Results.

Initial MGC026 (B7-H3 ADC) Phase 1 results in mid-2026 Initial MGC028 (ADAM9 ADC) Phase 1 results in second half of 2026 Lorigerlimab Phase 2 LINNET study update in mid-2026 IND submission for MGC030, a first-in-class TOP1i-based ADC, on track for 3Q 2026 Cash, cash equivalents and marketable securities of $189.9 million as of December 31, 2025; cash runway guidance remains into late 2027ROCKVILLE, Md., March 09, 2026 (GLOBE NEWSWIRE) — MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today provided an update on its recent corporate progress, reported financial results for the year ended December 31, 2025, and highlighted anticipated data disclosure timelines for its product pipeline. “I am excited about MacroGenics’...

Stereotaxis Reports 2025 Full Year Financial Results

Written by Customer Service on March 9, 2026. Posted in Earnings Releases And Operating Results.

ST. LOUIS, March 09, 2026 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial results for the fourth quarter and full year ended December 31, 2025. “The past year saw tremendous progress with significant regulatory approvals globally, advancement of a broad pipeline of innovations, and revenue growth of over 20%. I’m proud of what our team has accomplished and excited for the year ahead,” said David Fischel, Chairman and CEO. “The highlight of the past year was achieving regulatory approvals in the United States and Europe for the GenesisX robot, MAGiC ablation catheter, and MAGiC Sweep high density mapping catheter. This core product portfolio serves as a foundation for significant commercial growth as the only...

Frequency Holdings (OTC FRQN) Announces Verified in Microsoft AI Cloud Partner Program

Written by Customer Service on March 9, 2026. Posted in Public Companies.

ReachOut is Guiding Organizations in Deploying AI Securely Inside Real Business Operations Chicago, IL, March 09, 2026 (GLOBE NEWSWIRE) — Frequency Holdings Inc. (OTC FRQN) announced today that its subsidiary ReachOut Digital Intelligence has been verified in the Microsoft AI Cloud Partner Program, positioning the Company to expand consulting and operational services around enterprise AI deployments built on the Microsoft Cloud.ReachOut Digital Intelligence is a Verified Microsoft AI Cloud Partner The Microsoft AI Cloud Partner Program is Microsoft’s ecosystem for companies delivering solutions built on Microsoft cloud and AI technologies, providing partners with tools, training, and resources to deploy customers on Microsoft’s AI and cloud platform. This verification milestone formalizes work already underway helping customers...

U.S. Energy Corp. Announces Pricing of Underwritten Offering of Common Stock

Written by Customer Service on March 9, 2026. Posted in Public Companies.

HOUSTON, March 09, 2026 (GLOBE NEWSWIRE) — U.S. Energy Corp. (NASDAQ: USEG, “U.S. Energy” or the “Company”) today announced the pricing of its underwritten offering of 8,800,000 shares of its common stock, par value $0.01 per share (“common stock”), at an offering price of $1.00 per share, for total gross proceeds, $8.8 million. The offering is expected to close on March 10, 2026, subject to customary closing conditions. U.S. Energy plans to use the net proceeds of the offering to fund growth capital for its industrial gas development project, including processing plant and infrastructure, and to support upcoming operations. Roth Capital Partners is acting as sole book-running manager for the offering. The offering is being made pursuant to a shelf registration statement on Form S-3, including a base prospectus, which was filed...

Espey Announces Regular Quarterly Dividend of $0.25 Per Share

Written by Customer Service on March 9, 2026. Posted in Dividend Reports And Estimates.

SARATOGA SPRINGS, N.Y., March 09, 2026 (GLOBE NEWSWIRE) — The Board of Directors of Espey Mfg. & Electronics Corp. (NYSE AMERICAN: ESP) has declared a regular quarterly dividend of $0.25 per share. The dividend will be payable on March 27, 2026 to all shareholders of record on March 20, 2026. Espey’s primary business is the development, design, and production of specialized military and industrial power supplies/transformers. The Company can be found on the Internet at www.espey.com. For further information, contact Ms. Kaitlyn O’Neil at invest@espey.com. Certain statements in this press release are “forward-looking statements” and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements represent the Company’s current...

McEwen Q4 and Year-End 2025 Results Conference Call

Written by Customer Service on March 9, 2026. Posted in Public Companies.

TORONTO, March 09, 2026 (GLOBE NEWSWIRE) — McEwen Inc. (NYSE/TSX: MUX) (“McEwen”, “MUX” or the “Company”) invites you to join our Q4 and year-end 2025 conference call that will take place on Thursday, March 12, 2026, at 3:00 PM EDT. Management will discuss our financial results and project developments and follow with a question-and-answer session. Participants can ask questions directly over the phone during the webcast.Thursday,March 12, 2026at 3:00 PM EDT Toll Free North America: (888) 210-3454Toll Dial-In: (646) 960-0130International Dial-In: https://events.q4irportal.com/custom/access/2324/Conference ID Number: 3232920Webcast Link: https://events.q4inc.com/attendee/594254930/guestAn archived replay of the webcast will be available approximately two hours after the conclusion of the live...

Brad Zoelle Named President of Boston Whaler Aligning the Brand for Next Phase of Growth

Written by Customer Service on March 9, 2026. Posted in Public Companies.

METTAWA, Ill., March 09, 2026 (GLOBE NEWSWIRE) — Brunswick Boat Group, a division of Brunswick Corporation (NYSE: BC), today announced the appointment of Brad Zoelle as President of Boston Whaler. Zoelle, who most recently served as General Manager of Mercury Marine APAC, succeeds Lenn Scholz, who is pursuing new opportunities outside the Company. Zoelle brings a proven record of strategic leadership and commercial impact across the Brunswick portfolio through a series of high-impact roles at Mercury Marine and Sea Ray. Most recently as General Manager of Mercury Marine APAC, he spearheaded international market expansion and drove significant growth across the propulsion and P&A segments. His strategic leadership extended to Sea Ray, where he drove the launch of flagship models like the SLX-R 400e earning recognition at the...

Dassault Aviation: Total number of shares and voting rights – 06 03 26

Written by Customer Service on March 9, 2026. Posted in Public Companies.

DASSAULT AVIATION French corporation (société anonyme) with a share capital of 62,170,196.80 euros Headquarters: 78, quai Marcel Dassault 92210 SAINT-CLOUD 712 042 456 RCS Nanterre Information concerning the total number of voting rights and shares as per article L. 233-8 II of the French Commercial Code (Code de commerce) and article 223-16 of the General Regulations (Règlement Général) of the French Market Authority (Autorité des Marchés Financiers)DateTotal number of sharesTotal number of voting rights03/06/2026 77,712,746Theoretical voting rights: 129,882,307 Exercisable voting rights: 129,736,109AttachmentTotal number of shares and voting rights – 06 03 26

Day: March 9, 2026

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals